Keyphrases
Crohn's Disease
63%
Inflammatory Bowel Disease
60%
Pediatric Inflammatory Bowel Disease
51%
Pediatric Patients
44%
Pediatric Crohn's Disease
31%
Pediatric
24%
Granulocyte Colony-stimulating Factor (G-CSF)
24%
Infliximab
21%
Hepatocytes
21%
Ulcerative Colitis
20%
Hepatocyte Apoptosis
19%
Crohn's Colitis
16%
Apoptosis
15%
Nuclear factor-κB
15%
Confidence Interval
13%
Corticosteroids
12%
Remission
12%
Budesonide
12%
Delayed Diagnosis
11%
Hepatocyte Proliferation
11%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
11%
NOD2
10%
Ileitis
10%
Autoantibodies
10%
Gene-deficient Mice
9%
Pragmatic Trial
9%
Protein Expression
9%
Improved Outcomes
9%
Monotherapy
9%
Tumor Necrosis Factor-α
9%
Pragmatic Clinical Trial
9%
Odds Ratio
8%
Ileal Crohn's Disease
8%
Obstructive Jaundice
8%
Low-dose Methotrexate
8%
Statural Growth
8%
Expected Growth
8%
Growth Plate Closure
8%
Comparative Effectiveness
8%
Non-alcoholic Fatty Liver Disease (NAFLD)
8%
Learning Health System
8%
Anti-tumor Necrosis Factor (anti-TNF)
8%
Monogenic
8%
Clinical Endpoints
8%
Healthcare Research
8%
Systemic Corticosteroids
8%
Older Adults
8%
Colitis
8%
Histoplasmosis
8%
Older Adolescents
8%
Medicine and Dentistry
Pediatrics
100%
Inflammatory Bowel Disease
75%
Crohn's Disease
57%
Pediatrics Patient
44%
Patient with Crohn's Disease
27%
Biological Product
24%
Tumor Necrosis Factor
18%
Quality Improvement
16%
Hepatocyte
16%
Programmed Cell Death
16%
Ulcerative Colitis
15%
Patient with Inflammatory Bowel Disease
15%
Therapeutic Drug Monitoring
12%
Adolescence
11%
Infliximab
10%
Health System
10%
Odds Ratio
9%
Colitis
9%
Electronic Health Record
8%
Nonalcoholic Fatty Liver
8%
Patient-Reported Outcome
8%
Outcome Assessment
8%
Clinical Trial
8%
Epiphyseal Plate
8%
Juvenile Idiopathic Arthritis
8%
Budesonide
8%
Fibrinogen
8%
Emergency Department
8%
Closed Head Injury
8%
Computer Assisted Tomography
8%
Cell Cycle
8%
Mating Hormone Alpha Factor
8%
Gut
8%
Infusion
8%
Protein Binding
8%
Necrosis
8%
Granulocyte Macrophage Colony Stimulating Factor
8%
Histoplasmosis
8%
Cancer Growth Factor
8%
Lymphocyte
8%
Immunity
8%
Immunosuppressant
8%
Case-Control Study
8%
Diagnostic Delay
8%
Drug Antibody
8%
HLA DQA1 Antigen
8%
Medical Record
7%
Immunoglobulin Enhancer Binding Protein
6%
Immunomodulating Agent
6%
Monoclonal Antibody
6%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
91%
Inflammatory Bowel Disease
42%
Tumor Necrosis Factor
36%
Biological Product
25%
Ulcerative Colitis
21%
Infliximab
17%
Remission
17%
Budesonide
16%
Granulocyte Macrophage Colony Stimulating Factor
16%
Immunoglobulin Enhancer Binding Protein
15%
Methotrexate
14%
Therapeutic Drug Monitoring
12%
Drug Antibody
10%
Monotherapy
9%
Ileitis
9%
Non-Steroidal Anti-Inflammatory Drug
9%
Autoantibodies
8%
Obstructive Jaundice
8%
Adalimumab
8%
Clinical Trial
8%
Necrosis
8%
Mating Hormone Alpha Factor
8%
Smad Protein
8%
Caspase
8%
Fibrinogen
8%
Mercaptopurine
8%
Binding Protein
8%
Histoplasmosis
8%
Cancer Growth Factor
8%
HLA DQA1 Antigen
8%
Placebo
7%
Disease Activity
7%
Combination Therapy
6%
Diseases
6%
Immunomodulating Agent
6%
Monoclonal Antibody
6%
Malignant Transformation
6%
Hexachlorophene
6%
